Neurocrine Biosciences trended higher with the broad market Thursday, coming within a penny of Tuesday’s high of $125.99. It is forming a bullish channel.
https://www.entrepreneur.com/finance/is-mid-cap-neurocrine-biosciences-a-buy-after-blowout-q3/438970
#financialfreedomllc #businesstips #business #entrepreneur #businessowner #entrepreneurship #marketing #smallbusiness #businesscoach #digitalmarketing #success #entrepreneurlife #motivation #businessideas #businessgrowth #businesswoman #businessman #businessquotes #businessowners #businessstrategy #startup #businesslife #businessmindset #businessminded #entrepreneurs #businessadvice #entrepreneurmindset #marketingtips #onlinebusiness #branding